Overview

Upstate Medical University and Empire State Development (ESD), in collaboration, provided an additional $4 million to Upstate Biotech Ventures (UBV), bringing the fund total to $10 million. State University of New York Chancellor John B. King Jr., made the announcement July 15. UBV is Upstate’s startup biotech fund, which is also supported ESD and SUNY, and managed by Excell Partners. This milestone comes about a year after the fund’s official launch in July 2024 with an initial $6 million in backing from Upstate and ESD.